TOP TIERMARKET NEWSWIRE
News & sentiment

KARYOPHARM THERAPEUT (KPTI) — News & AI sentiment

KARYOPHARM THERAPEUT (KPTI) news roundup. 2 stories in the past week, 4 over 30 days. Average 30-day sentiment is 48/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 4 sales totalling $3K — net selling of $3K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 46/100
30d stories
4
avg sentiment 48/100
Insider net (90d)
$3K
0 buys · 4 sells
Congress (90d)
0
0 buys · 0 sells

KPTI news in the last 24 hours, 7 days, 30 days and 90 days

How much KPTI coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowKPTI storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days246/100KPTI headlines →
Last 30 days448/100KPTI headlines →
Last 90 days3746.6/100KPTI headlines →

Latest stories on KPTI

6d ago
6d ago
Oct 14
Oct 1
Sep 18
Sep 11
Sep 11
Sep 11
Sep 11
Sep 1
Aug 31
Karyopharm submits sNDA to FDA for XPOVIO
The Fly63 · neutralproduct/pr
Aug 31
Aug 31
Aug 21
Karyopharm (KPTI) Q2 2026 Earnings Call Transcript
Yahoo Finance34 · bearishearnings
Aug 20
Karyopharm (KPTI) Q2 2026 Earnings Call Transcript
The Motley Fool34 · bearishearnings
Aug 20
Aug 17
Aug 14
Aug 13
Aug 13
KP Tissue Q2 GAAP EPS of $0.24, revenue of $550.89M
Seeking Alpha50 · neutralearnings
Aug 13
Aug 13
Aug 13
Aug 13
Aug 13
Open KPTI in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →